Equity Details
Price & Market Data
Price: $29.39
Daily Change: $0.00 / 0.00%
Daily Range: $29.39 - $29.39
Market Cap: $925,769,376
Daily Volume: 216
Performance Metrics
1 Week: 28.84%
1 Month: 28.84%
3 Months: 23.54%
6 Months: 68.37%
1 Year: -10.67%
YTD: 44.96%
About Xvivo Perfusion AB (publ) (XVIPF)
Discover the market presence of Xvivo Perfusion AB (publ) (XVIPF). Price: 29.39, daily change: $0.00 / 0.00%. Market cap: 925,769,376. Performance across all periods for a clear financial view.
Company Details
Employees: 210
Sector: Health technology
Industry: Medical specialties
Country: Sweden
Details
Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermic, sub-normothermic, or a combination; XVIVO System (XPS), a comprehensive ex vivo lung perfusion (EVLP) platform that offers an overview of the entire process; and STEEN Solution, a buffered extracellular solution intended for the assessment of isolated lungs after removal from the donor in preparation for eventual transplantation into a recipient. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XPS Disposable Lung Kit that contains all the necessary devices and tubing to run a normothermic EVLP procedure on the XPS; XVIVO Organ Chamber, a sterile single-use container intended to be used as a temporary receptacle for isolated donor lungs; and XVIVO Lung Cannula Set, a sterile single-use set that connects isolated donor lungs to an extracorporeal perfusion system for ex-vivo assessment. In addition, the company offers Kidney Assist that provides clinicians with a choice of perfusion protocols from hypothermic to normothermic perfusion; and Gisto, an integrated system for organ transportation. It operates in Sweden; The Netherlands; The United States; Italy; North and South America; Asia/Pacific and Oceania; and internationally. Xvivo Perfusion AB (publ) was incorporated in 1998 and is headquartered in Mölndal, Sweden.
